Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

280.48
Delayed Data
As of Feb 12
 +5.93 / +2.16%
Today’s Change
237.50
Today|||52-Week Range
340.34
-10.25%
Year-to-Date

Today’s Trading

Previous close274.55
Today’s open277.30
Day’s range272.23 - 280.48
Volume2,726,908
Average volume (3 months)4,056,162
Market cap$108.2B
Dividend yield--
Data as of 4:02pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+10.36%
Earnings growth (next 5 years)+10.02%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.61+1.59%
BMYBristol-Myers Squibb+0.68+1.14%
NVONovo Nordisk+0.18+0.37%
GSKGlaxoSmithKline+0.61+1.56%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$3.34
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers